The global benign prostatic hyperplasia (BPH) treatment devices and equipment market size is expected to grow from $1.33 billion in 2021 to $1.48 billion in 2022 at a compound annual growth rate (CAGR) of 10.7%. The global BPH treatment devices and equipment market size is expected to grow to $2.1 billion in 2026 at a CAGR of 9.2%.
What is the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market?
The benign prostatic hyperplasia (BPH) treatment devices and equipment market consist of sales of benign prostatic hyperplasia treatment devices and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of an enlarged prostate gland that causes blockage of the urethra, the tube that carries urine from the bladder.
Get a Sample of the global benign prostatic hyperplasia (BPH) treatment devices and equipment market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp
What drives the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market?
Benign Prostatic Hyperplasia (BPH) also called Prostate Gland Enlargement (PGE), is a condition where the patient suffers from uncomfortable urinary symptoms. Due to the rising prevalence of Benign Prostatic Hyperplasia, demand for the BPH treatment devices and equipment is on a steady rise as the number of BPH cases increases the demand for devices will also increase. For example, in 2021, more than 14 million men in the United States have symptoms of BPH. Globally 30 million men have symptoms related to BPH. Therefore, with the number of BPH cases on the steady rise, the demand for BPH treatment devices and equipment is also expected to grow.
Get the full global benign prostatic hyperplasia (BPH) treatment devices and equipment industry report here
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-reportGlobal Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market Segments
The global benign prostatic hyperplasia (BPH) treatment devices and equipment market is segmented:
By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home
By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection of Prostate (TURP), Transurethral Incision of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Others
By Geography: The regions covered in the benign prostatic hyperplasia (BPH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Global Market Report 2022provides market size and growth forecasts for the global benign prostatic hyperplasia (BPH) treatment devices and equipment market, global benign prostatic hyperplasia treatment devices and equipment market share, benign prostatic hyperplasia treatment devices and equipment market segments and geographies, BPH treatment devices and equipment market competitive landscape including leading competitors’ revenues, profiles and market shares. The BPH treatment devices and equipment market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Industry Playersinclude Karl Storz, Lumenis, Olympus, Urologix, Boston Scientific Inc., Endo International, Neo tract, Lisa Laser, Medifocus Inc., ProArc Medical LTD., and Olympus America. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.